| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Glycosaminoglycan degradation 0.9676875526833362 2.6757759386589317 0.0074556470555764 0.9897445964859972 0.9238573496407446 5 P16278,P15586,P06865,P54802 4 |
| Degradation pathway of sphingolipids including diseases 0.9217430614437174 2.6756124146910345 0.0074592852901724 0.9897675769453724 0.9238573496407446 7 P17900,P06865,P16278,P07686,P15289 5 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.8013393185855415 2.168615519598652 0.0301118859287381 0.9999999925244714 0.9238573496407446 6 P07099 1 |
| Cholesterol biosynthesis with skeletal dysplasias 0.7805024843973707 2.077457210263295 0.0377593806319078 0.9999999999411676 0.9238573496407446 6 Q15392,Q16850 2 |
| Cellular proteostasis 0.7933070826783892 1.8014579559514765 0.0716307284115203 1.0 0.9238573496407446 4 Q9NQP4,Q9UHV9 2 |
| Kennedy pathway from sphingolipids 0.7885415818867101 1.7816907289271513 0.074799679595098 1.0 0.9238573496407446 4 P35790,Q9UG56 2 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.7865168539325941 1.77328265746098 0.0761818813045218 1.0 0.9238573496407446 4 Q03252,P02545,O60725 3 |
| Eicosanoid metabolism via lipooxygenases lox 0.7108579724349773 1.766437627541501 0.077322457053738 1.0 0.9238573496407446 6 Q8N8N7,Q14914 2 |
| Oxidation by cytochrome p450 0.7389102821611575 1.7275998005852649 0.0840599985986432 1.0 0.9238573496407446 5 Q16850 1 |
| Striated muscle contraction pathway 0.7003488621178555 1.718712130646847 0.0856668021019575 1.0 0.9238573496407446 6 P67936,P08670 2 |
| Ketogenesis and ketolysis 0.6896067854334836 1.6697331763054646 0.0949721666879752 1.0 0.9238573496407446 6 O43772,P23786 2 |
| Mitochondrial complex iii assembly 0.6932034725794346 1.6581805463264767 0.0972810301136313 1.0 0.9238573496407446 10 P22695,Q9UDW1,Q6DKK2 3 |
| Sphingolipid pathway 0.6887079118249871 1.6567412927478016 0.0975717907456514 1.0 0.9238573496407446 7 Q06136,P04062,Q13510 3 |
| Sphingolipid metabolism integrated pathway 0.717441845567012 1.633956747114831 0.1022679329187656 1.0 0.9238573496407446 5 Q06136,Q13510 2 |
| Sphingolipid metabolism overview 0.717441845567012 1.633956747114831 0.1022679329187656 1.0 0.9238573496407446 5 Q06136,Q13510 2 |
| Estrogen receptor pathway 0.7490394146478603 1.6166905495233808 0.105945094893616 1.0 0.9238573496407446 4 Q9HCL2,P08047 2 |
| Tyrobp causal network in microglia 0.698427469330648 1.5505026543894296 0.1210209168936011 1.0 0.9238573496407446 5 P61916 1 |
| Familial partial lipodystrophy fpld 0.6427195962347545 1.4437050676341283 0.148821955342882 1.0 0.9238573496407446 7 Q03252,O75844,O60725 3 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.6318494838817175 1.392979025166889 0.1636261334918876 1.0 0.9238573496407446 7 P06753 1 |
| Glycerolipids and glycerophospholipids 0.6512529165679215 1.341844498876554 0.1796464204994818 1.0 0.9238573496407446 5 Q9HCL2,O96017,Q9UG56 3 |
| Eicosanoid metabolism via cyclooxygenases cox 0.6165789725936766 1.3324663721921857 0.1827069845671234 1.0 0.9238573496407446 6 Q8N8N7,Q14914 2 |
| Influence of laminopathies on wnt signaling 0.6192709714096342 1.3244009487874224 0.1853699196636191 1.0 0.9238573496407446 8 P50402,O75844,O60725 3 |
| 1q211 copy number variation syndrome 0.6229455858481652 1.319408945013688 0.1870324329181132 1.0 0.9238573496407446 11 Q9UDY2,Q07157,Q16625,Q13131,Q9NPH0 5 |
| Nanoparticle triggered autophagic cell death 0.6138131351126541 1.2986946644135802 0.1940487358956526 1.0 0.94252243149317 8 Q14457,Q9H1Y0 2 |
| Pregnane x receptor pathway 0.598642671020607 1.1080629881811377 0.2678346139442358 1.0 1.0 5 P08183 1 |
| 7oxoc and 7betahc pathways 0.5746230200675648 1.1041005242787083 0.2695495338839566 1.0 1.0 9 O15118,P61916 2 |
| Heme biosynthesis 0.5957229360835146 1.095114437866733 0.2734665041814295 1.0 1.0 5 P22830 1 |
| Constitutive androstane receptor pathway 0.5604030306316181 1.070597656490641 0.2843503776645295 1.0 1.0 6 Q99615,P08183,P08047 3 |
| Sphingolipid metabolism in senescence 0.549705546747026 0.9548032855332402 0.3396771855883713 1.0 1.0 13 P16278,P04062,Q13510 3 |
| Endoplasmic reticulum stress response in coronavirus infection 0.5289345137487262 0.91200690954653 0.3617650802748549 1.0 1.0 7 P62136,P19525,Q15435,P62140 4 |
| Il10 antiinflammatory signaling pathway 0.5476673937812573 0.8836796395256133 0.3768691743448467 1.0 1.0 5 P09601 1 |
| Preimplantation embryo 0.5113312315495608 0.8311119222455897 0.4059104052274493 1.0 1.0 7 P17096,Q92945 2 |
| Neuroinflammation 0.5321117259446932 0.8163574344840366 0.4142957340732052 1.0 1.0 5 P00403 1 |
| Vitamin b12 disorders 0.531402506479844 0.8133068308656791 0.4160421616093877 1.0 1.0 5 Q96EY8,Q9H3L0 2 |
| Cholesterol biosynthesis pathway 0.509830705211093 0.7728182684327088 0.4396299402359622 1.0 1.0 12 Q15800,P37268,Q16850 3 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5121710222397724 0.7699227458949073 0.4413457203730297 1.0 1.0 14 P50402,O75844,P55209,O60725 4 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.5191020158388613 0.7606996461382827 0.4468364862281033 1.0 1.0 5 Q9BXK5 1 |
| Oxidative stress response 0.4913927243237334 0.728394073800759 0.4663723899296736 1.0 1.0 8 P09601,Q16881,P08047 3 |
| Nephrotic syndrome 0.4849124670527708 0.6505340700077935 0.5153473017989831 1.0 1.0 13 O75844,Q14108 2 |
| Interactome of polycomb repressive complex 2 prc2 0.4783980460227933 0.6480542600145489 0.5169498564044472 1.0 1.0 10 O75530,Q9NYF8,Q9Y2W1,Q15208 4 |
| Translation factors 0.4483298388796004 0.6187150738029394 0.5361040779507333 1.0 1.0 39 P55010,O60841,Q9H074,P19525,O00303,Q15056,P41567,P29692,O75153,Q13144,O75822,P23588,P49770,Q14240,P62495 15 |
| Progeriaassociated lipodystrophy 0.4596747807868144 0.5660643508236066 0.5713500361797124 1.0 1.0 10 Q03252,O75844,O60725 3 |
| Proteasome degradation 0.4233298202963493 0.5435494367511677 0.5867515625548283 1.0 1.0 42 P28070,P25787,P28072,P16104,P04439,P10321,P61289,P20618,P04844,Q9UL46,P49721 11 |
| Nephrogenesis 0.7619314991577815 0.4840125237767999 0.6283769810809006 1.0 1.0 2 Q04721 1 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.4389866869700263 0.4788353117668902 0.6320557934872688 1.0 1.0 10 P04792,O60333,P20337,Q13614,P50570 5 |
| Ccl18 signaling pathway 0.4240137731846608 0.4408079349373845 0.6593520485355857 1.0 1.0 8 P08670 1 |
| Molybdenum cofactor moco biosynthesis 0.5179311362941805 0.4049832237456213 0.6854898425321241 1.0 1.0 3 O96007 1 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.4299956221426896 0.3992345504136343 0.689720387495941 1.0 1.0 15 O15372,P55010,O00303,P41567,O75822,O75821 6 |
| Ferroptosis 0.433959708174551 0.3937045271606303 0.6937991985851522 1.0 1.0 27 Q96QD8,P02786,Q9Y277,Q9H1Y0,P37268,Q16881,Q9NZZ3,P09601,P45880,Q15043 10 |
| Allograft rejection 0.420696692916884 0.3859481671953169 0.6995350567660854 1.0 1.0 12 P04439,P08183,P08670 3 |
| Autophagy 0.4185980761290791 0.3612827263643152 0.7178881052920199 1.0 1.0 14 Q13131,Q14457,Q9H1Y0 3 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.3994886938521879 0.358979802241845 0.7196101990717791 1.0 1.0 7 Q07157 1 |
| Hostpathogen interaction of human coronaviruses autophagy 0.4010014415112973 0.3526091243963926 0.7243814961704682 1.0 1.0 8 Q9H1Y0 1 |
| Onecarbon metabolism and related pathways 0.4141248316530079 0.351986835968713 0.7248481349164737 1.0 1.0 13 P34896,P35790 2 |
| Mrna processing 0.2881920973430037 0.321426579189743 0.7478871436009393 1.0 1.0 107 P52756,O94992,P22626,Q14103,P83876,P61978,P26368,Q15428,P62995,Q15233,Q8IYB3,O75494,P55795,O43390,Q15427,Q08170,Q13242,O75937,P67809,P84103,Q99729,Q13243,Q07955,Q16629,P38159,P35637,P23246,Q15287,P49755,P31943 30 |
| Primary focal segmental glomerulosclerosis fsgs 0.4035174523236026 0.270981563378776 0.7864052122178959 1.0 1.0 20 Q14108 1 |
| Vitamin d metabolism 0.406261436644889 0.2671401959265295 0.7893612199213211 1.0 1.0 4 P04062 1 |
| Pparalpha pathway 0.3635431141084554 0.2358845924603881 0.8135222243674813 1.0 1.0 7 P06493,P23786 2 |
| Dopamine metabolism 0.449939934613641 0.2252574526637639 0.8217789969345137 1.0 1.0 3 P21964 1 |
| Adipogenesis 0.3882734523755992 0.2207622487630523 0.8252775594668442 1.0 1.0 19 P02545,O75844,P14174,P17096,P08047 5 |
| Nuclear receptors metapathway 0.318088666073992 0.2002829257376799 0.8412593152996699 1.0 1.0 52 Q99615,Q14914,Q16543,Q86UP2,P08183,P30043,Q16881,P09601,P04150,P00390,P06493,P23786,P08047,P22307,Q15067,Q15043,Q9HCL2 17 |
| 3q29 copy number variation syndrome 0.3742300142513512 0.1976536167335225 0.8433160821502117 1.0 1.0 15 P02786,O95684 2 |
| Gastric cancer network 1 0.354674323503802 0.1789803250873015 0.8579531505388249 1.0 1.0 10 P33991 1 |
| Id signaling pathway 0.603593486805178 0.1403349831538956 0.8883953252430776 1.0 1.0 2 P24941 1 |
| Disruption of postsynaptic signaling by cnv 0.3324457086336203 0.1374854157100121 0.8906471198524883 1.0 1.0 8 Q13555,P61981,Q07157 3 |
| Congenital generalized lipodystrophy cgl 0.5982594048287606 0.1328187421503955 0.8943367315899176 1.0 1.0 2 P62993 1 |
| Electron transport chain oxphos system in mitochondria 0.3302133103439179 0.1218432341098743 0.9030231731428182 1.0 1.0 46 P00403,P56385,P22695,P14406,P06576,O96000,O75964,Q9UII2,Q9UDW1,P14927 10 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.3599536067810184 0.117340881547283 0.906589929989194 1.0 1.0 23 Q15392,P48449,Q16850,P37268,Q15800 5 |
| Biomarkers for urea cycle disorders 0.5825379000561617 0.1122793978930608 0.9106018765995008 1.0 1.0 2 Q14353 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.3325051458987016 0.1046036984499246 0.91669027987047 1.0 1.0 12 Q96AY3,Q32P28 2 |
| Cohesin complex cornelia de lange syndrome 0.3469083570269758 0.1022194825875429 0.9185824638864142 1.0 1.0 18 Q9UQE7,Q9NTI5,Q29RF7,Q15257,P30153,P06493,P30154,Q14674 8 |
| Proteoglycan biosynthesis 0.5735541830432478 0.101609208463905 0.91906686998633 1.0 1.0 2 Q8TB61 1 |
| Copper homeostasis 0.3185734163296211 0.0970611390396223 0.9226778416541236 1.0 1.0 5 P08047 1 |
| Matrix metalloproteinases 0.5651319483436413 0.0922952466456448 0.9264634648792508 1.0 1.0 2 P35613 1 |
| 15q112 copy number variation syndrome 0.3720864925582696 0.0892501980002009 0.9288830722830734 1.0 1.0 3 Q9BSJ2,Q96CW5 2 |
| Airway smooth muscle cell contraction 0.3116043832537284 0.0846636140281314 0.9325288238668534 1.0 1.0 5 O75116,Q13464,P61586,P62140 4 |
| Notch signaling 0.3072538061848752 0.080428226421599 0.9358966781792106 1.0 1.0 8 Q92542,Q04721,Q8TDB6 3 |
| Spinal cord injury 0.3448512561936441 0.0799436188952735 0.9362820979622326 1.0 1.0 22 P04083,P08670,P14174,Q9NQC3 4 |
| Nanoparticle triggered regulated necrosis 0.3504879426773947 0.0654109658684616 0.9478467932789458 1.0 1.0 3 Q14790 1 |
| Complement system 0.306696679797425 0.0642259423850647 0.9487903209983156 1.0 1.0 10 Q07021,P17612,P08754,P48729,P04899,P27797,P26885,P39019,P17252 9 |
| Mammary gland development pathway embryonic development stage 1 of 4 0.5303200449186007 0.0605235530206128 0.9517386576346942 1.0 1.0 2 P01106 1 |
| Interactions between loxl4 and oxidative stress pathway 0.2979261970851234 0.0550627780178573 0.9560884499727952 1.0 1.0 4 Q16543 1 |
| Cannabinoid receptor signaling 0.2780620930125394 0.0369945371782756 0.970489361460793 1.0 1.0 7 Q8NCG7 1 |
| Cardiac progenitor differentiation 0.4848399775407255 0.0333592140559705 0.9733881340146469 1.0 1.0 2 P13591 1 |
| Gpr40 pathway 0.4736103312745833 0.0287265310197079 0.9770826964023328 1.0 1.0 2 P19174 1 |
| Tumor suppressor activity of smarcb1 0.3127133062407581 0.0283087788245632 0.9774158789176626 1.0 1.0 18 Q92785,Q92925,Q09028,Q969G3,Q15910,O75530,Q12824,P11802,P42771 9 |
| Mecp2 and associated rett syndrome 0.3242197620290798 0.0216601376704976 0.9827190618370724 1.0 1.0 26 P35637,Q8NAV1,P67809,P52597,P31943,Q99640,P08047 7 |
| Arrhythmogenic right ventricular cardiomyopathy 0.2958364197122994 0.0207784434352373 0.9834223936736386 1.0 1.0 14 P50402,P02545 2 |
| Leptininsulin signaling overlap 0.3728242560359482 0.0100377236761351 0.9919911897425752 1.0 1.0 2 O14654 1 |
| Cell differentiation expanded index 0.3728242560359492 0.0100377236761351 0.9919911897425752 1.0 1.0 2 Q15910 1 |
| Energy metabolism 0.2882498894207945 0.0097668021728926 0.9922073432288364 1.0 1.0 14 Q13555,P54619,Q13131,Q8WVM0 4 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.2780600300149202 0.0068662225251846 0.9945215901027686 1.0 1.0 12 O94992,P08047 2 |
| Oxysterols derived from cholesterol 0.2540707464222811 0.0068290275354179 0.9945512667150652 1.0 1.0 7 Q15125 1 |
|
|
